Md. Salahuddin was born in chaipainawabganj, Bangladesh on 1st June, 1965. He got M.SC in Biochemistry from Rajshahi University, Bangladesh in 1990. He worked about four years in Pharmaceuticals Industry and joined in Directorate General of Drug Administration on March 27, 1994 as Superintendent of Drugs and promoted as Assistant Director on February 22, 2011.
He has been working for 24 years in Directorate General of Drug Administration (DGDA ), Bangladesh in different capacities such as post marketing surveillance of pharmaceuticals, Good Pharmacy Practice Inspection, Good Manufacturing Practice Inspection, Dossier Evaluation of Pharmaceuticals, Medical Devices, Vaccines and Biologics for Registration (marketing authorization), / licensing, pharmacovigilance activities, good clinical practice inspection, clinical trial protocol evaluation and approval, good laboratory Practice inspection etc. He is member secretary of Clinical Trial Advisory Committee of DGDA .He is in charge of vaccine registration desk in DGDA. He is focal person of South –East Asia Regulatory Network (SEARN) for DGDA , He is focal person for international desk of DGDA, He is focal person for DGDA maturity level-3 activities ( DGDA prequalification activities from WHO).
Md Salahuddin has developed Guidelines for DGDA on Good Clinical Practice (GCP) guidelines, Medical Devices Registration Guidelines, Standardization and Quality Control Parameter Required for Ayurvedic, Unani and Herbal Medicines, DGDA Quality Manual, Biosimilar Registration guidelines, Cosmetics Regulation Guidelines etc. as member secretary.
Salahuddin is married and blessed with one son and two daughters. He loves sight-seeing and reading. He visited USA, South Korea, Singapore, Spain, Indonesia, Tunisia, Thailand, Tanzania Denmark, Germany, Japan, Malaysia ,Turkey, Nepal and India for participating workshop and training program on TQM for pharmaceuticals, Lot release of vaccines, Regulatory affairs management, clinical trial, Drug development etc. He also works as a trainer on GMP, GCP and Pharmaceuticals matters.